ESMO World Congress on GI Cancer 2023

John L. Marshall M.D., shares insights on health-related quality of life (HRQoL) findings from SUNLIGHT study presented at ESMO World Congress on Gastrointestinal Cancer (ESMO GI) 2023.

Discussion on shared decision making with patients with later stage refractory metastatic colorectal cancer as well as maximizing a patient's quality of life.

Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.

An overview of data presented at ESMO GI 2023 on combined botensilimab and balstilimab therapy in heavily pretreated patients with microsatellite stable metastatic colorectal cancer.

Dr Marshall discusses challenges associated with microsatellite stable metastatic colorectal cancer.

The LEAP-017 trial results presented at ESMO GI 2023 are explored by Dr Marshall.

John L. Marshall M.D., explains the importance of in-person conferences and the future of AI in the field.